Compare · NXT vs TMO
NXT vs TMO
Side-by-side comparison of Nextpower Inc. (NXT) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NXT and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $177.93B, about 10.1x NXT ($17.69B).
- Over the past year, NXT is up 187.5% and TMO is up 12.2% - NXT leads by 175.2 points.
- NXT has been more active in the news (25 items in the past 4 weeks vs 10 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Nextpower Inc.
- Thermo Fisher Scientific Inc
- Price
- $120.19+0.86%
- $471.01-1.74%
- Market cap
- $17.69B
- $177.93B
- 1M return
- -0.17%
- -4.75%
- 1Y return
- +187.47%
- +12.25%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2023
- News (4w)
- 25
- 10
- Recent ratings
- 25
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NXT
- Nextpower Inc. filed SEC Form 8-K: Leadership Update
- Chief Executive Officer Shugar Daniel S disposed of $17,817,140 worth of shares (150,958 units at $118.03) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 736,272 units (SEC Form 4) to satisfy withholding obligation
- Chief Operating Officer Miller Nicholas Marco disposed of $4,751,298 worth of shares (40,256 units at $118.03) as part of a pre-agreed trading plan, decreasing direct ownership by 19% to 166,357 units (SEC Form 4) to satisfy tax liability
- Chief Legal & Compliance Ofc Ledesma Bruce disposed of $6,335,106 worth of shares (53,675 units at $118.03) as part of a pre-agreed trading plan, decreasing direct ownership by 22% to 192,205 units (SEC Form 4) to cover withholding tax
- President Wenger Howard disposed of $9,502,596 worth of shares (80,512 units at $118.03) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 403,668 units (SEC Form 4) to cover taxes
- Chief Accounting Officer Bennett David P disposed of $7,918,797 worth of shares (67,093 units at $118.03) as part of a pre-agreed trading plan, decreasing direct ownership by 35% to 126,482 units (SEC Form 4) to satisfy withholding tax
- SEC Form 144 filed by Nextpower Inc.
- SEC Form 144 filed by Nextpower Inc.
- SEC Form 144 filed by Nextpower Inc.
- SEC Form 144 filed by Nextpower Inc.
Latest TMO
- SEC Form 10-Q filed by Thermo Fisher Scientific Inc
- President & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)
- Thermo Fisher Scientific to Host Investor Day
- Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc